No definition available.
Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)
C3_BILIARY_GALLBLADDER_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
2374 |
4. Check minimum number of eventsNone |
2374 |
5. Include endpoints |
2374 |
6. Filter based on genotype QC (FinnGen only) |
2374 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of liver and intrahepatic bile ducts
- Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)
- Hepatocellular carcinoma
- Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2374 | 772 | 1602 |
| Unadjusted period prevalence (%) | 0.56 | 0.26 | 0.71 |
| Median age at first event (years) | 71.56 | 70.53 | 72.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1517
- Matched controls
- 15169
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
323.0
503
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
99.4
323.0
387
52
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
323.0
666
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
323.0
312
*
Z51.5
ICD-10 Finland
Palliative care
34.5
323.0
457
187
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
726
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
323.0
304
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
132.8
323.0
437
46
A03FA01
ATC
metoclopramide; systemic, rectal
13.4
323.0
641
784
A04AA02
ATC
granisetron; systemic, transdermal
590.9
258.0
249
5
N02AA05
ATC
oxycodone; systemic
9.4
257.9
620
1035
H02AB02
ATC
dexamethasone; systemic
51.2
244.8
295
71
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
844.8
227.3
218
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
226.9
212
*
JN4CD
NOMESCO Finland
Very extensive body CT
34.6
201.6
265
92
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
11.2
189.4
388
453
L01BC06
ATC
capecitabine; oral
+∞
184.2
173
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
180.9
170
*
JN4BD
NOMESCO Finland
Extensive body CT
12.7
178.8
340
338
WX302
NOMESCO Finland
Thoracal epidural anesthesy
30.6
177.7
241
93
K83.1
ICD-10 Finland
Obstruction of bile duct
61.1
172.8
202
38
198
Kela drug reimbursment
Sorafenib
+∞
170.0
160
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
167.9
158
*
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
164.6
155
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
538.9
150.3
147
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
149.5
141
*
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
149.5
141
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
34.2
142.2
187
62
UJK02
NOMESCO Finland
ERCP
16.6
134.9
224
157
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
34.2
127.9
168
55
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
59.3
127.7
150
28
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
126.8
120
*
JN4AD
NOMESCO Finland
Body CT examination
14.0
126.8
226
187
L01XE05
ATC
[U] sorafenib; oral
+∞
120.4
114
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
167.0
118.1
123
8
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.1
112.0
160
71
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
28.7
111.4
153
59
A04AA01
ATC
ondansetron; systemic, rectal
21.3
108.5
163
85
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
13.7
107.1
192
159
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
11.2
106.9
212
217
JLC30
NOMESCO Finland
Pancreatoduodenectomy
281.9
104.2
105
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.9
104.0
539
1874
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.9
99.7
372
938
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
22.5
99.6
147
72
R18
ICD-10 Finland
Ascites
23.8
98.7
143
66
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
36.3
98.3
127
38
K83.0
ICD-10 Finland
Cholangitis
20.3
94.4
144
78
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.5
94.1
239
370
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.8
93.8
292
595
8140/3-C23.9
ICD-O-3
Adenocarcinoma, NOS, of gallbladder
+∞
93.7
89
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
93.7
89
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
30.4
93.4
126
45
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
23.2
91.9
134
63
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
97.8
84.0
92
10
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.7
83.9
179
207
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
14.5
81.5
141
106
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
78.8
75
*
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
+∞
78.8
75
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
775.3
75.9
74
*
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
30.1
73.4
99
35
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
16.2
72.2
119
79
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
71.4
68
*
116
Kela drug reimbursment
Prostate cancer
+∞
69.3
66
*
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
+∞
69.3
66
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
244.3
68.8
70
*
WZC30
NOMESCO Finland
Teaching
4.7
68.6
257
630
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
67.2
64
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
12.7
65.0
119
101
WF002
NOMESCO Finland
Radical radiotherapy
118.5
63.4
68
6
D77
ICPC
Malignant digestive neopl other/NOS
643.7
63.3
62
*
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
62.9
60
*
323
Kela drug reimbursment
Sorafenib
+∞
62.9
60
*
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
61.9
59
*
C24.00
ICD-10 Finland
Hepatic duct
+∞
61.9
59
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
24.9
61.3
87
37
A09AA02
ATC
multienzymes (lipase, protease etc.)
14.4
60.3
104
77
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
59.8
57
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
59.8
57
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
600.3
59.1
58
*
JN3AD
NOMESCO Finland
Abdominal CT examination
5.1
58.5
197
427
8140/3-C24.1
ICD-O-3
Adenocarcinoma, NOS, of ampulla of Vater
+∞
57.7
55
*
Z94.4
ICD-10 Finland
Liver transplant status
93.8
57.3
63
7
B01AB05
ATC
enoxaparin; parenteral
2.7
57.3
520
2476
XX3DW
NOMESCO Finland
Time consuming IT work
6.4
57.1
159
273
A04AA55
ATC
palonosetron, combinations; systemic
+∞
54.5
52
*
C24.02
ICD-10 Finland
Common bile duct
+∞
54.5
52
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
120.5
54.2
58
5
R50.9
ICD-10 Finland
Fever, unspecified
3.4
54.1
299
1018
B01AB10
ATC
tinzaparin; parenteral
6.4
53.2
147
249
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
52.5
282
938
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
52.4
531
2660
A05AA02
ATC
ursodeoxycholic acid; oral
21.5
51.4
76
37
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
84.6
51.2
57
7
JJC00
NOMESCO Finland
Allogenic transplantation of liver
182.8
51.2
53
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
49.7
409
1811
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
+∞
49.2
47
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
49.2
47
*
8160/3-C24.0
ICD-O-3
Cholangiocarcinoma of extrahepatic bile duct
+∞
48.2
46
*
8000/3-C24.9
ICD-O-3
Neoplasm, malignant of billiary tract, NOS
+∞
48.2
46
*
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
+∞
48.2
46
*
WW500
NOMESCO Finland
Blood transfusion
8.5
46.5
105
132
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
45.6
407
1875
C03DA01
ATC
spironolactone; oral
2.9
45.6
318
1262
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
45.0
43
*
N02AX02
ATC
tramadol; systemic, rectal
2.2
44.9
708
4327
L03AA02
ATC
filgrastim; parenteral
99.0
44.0
48
5
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
44.0
42
*
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
38.0
43.4
55
15
WX402
NOMESCO Finland
General anaesthesia
3.4
43.4
230
750
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
96.9
43.0
47
5
A06AH03
ATC
naloxegol; oral
42.2
42.7
53
13
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
37.2
42.4
54
15
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
428.9
42.4
42
*
127
Kela drug reimbursment
Transplant complication
17.2
41.4
66
40
A06AD11
ATC
lactulose; oral
2.5
41.4
385
1801
8140/3-C24.0
ICD-O-3
Adenocarcinoma, NOS, of extrahepatic bile duct
+∞
40.8
39
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
40.8
39
*
L02AE02
ATC
leuprorelin; implant, parenteral
60.5
40.4
47
8
8000/3-C22.1
ICD-O-3
Neoplasm, malignant of intrahepatic bile duct
+∞
38.7
37
*
J01MA12
ATC
levofloxacin; systemic
2.5
38.4
368
1739
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
47.3
38.0
46
10
8000/3-C24.0
ICD-O-3
Neoplasm, malignant of extrahepatic bile duct
+∞
37.6
36
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
23.3
37.6
54
24
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
102.6
36.9
40
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
36.6
35
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
36.6
35
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
36.4
215
754
A79
ICPC
Malignancy NOS
365.5
36.1
36
*
JJB30
NOMESCO Finland
Excision of two segments of liver
365.5
36.1
36
*
JAH01
NOMESCO Finland
Laparoscopy
7.0
35.8
91
137
JKA20
NOMESCO Finland
Cholecystectomy
5.7
35.6
106
197
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
29.6
34.4
46
16
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
344.4
34.0
34
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
33.4
32
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
32.4
31
*
JAH00
NOMESCO Finland
Laparotomy
6.7
31.8
83
130
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
20.2
31.4
47
24
3019
Kela drug reimbursment
Lenvatinib
+∞
31.3
30
*
A04AD12
ATC
aprepitant; systemic
+∞
31.3
30
*
ZX120
NOMESCO Finland
Intravenous
3.4
31.3
162
514
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
28.7
31.2
42
15
R4190
NOMESCO Finland
Nutritional therapy
8.8
30.9
67
79
A02BC02
ATC
pantoprazole; systemic
1.9
30.7
916
6775
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.7
30.5
108
244
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
30.4
676
4499
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
+∞
30.3
29
*
L02BB03
ATC
bicalutamide; oral
+∞
30.3
29
*
JJB10
NOMESCO Finland
Atypcal resection of liver
308.1
29.9
30
*
L01EX02
ATC
sorafenib; oral
+∞
29.3
28
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
29.3
28
*
1508
Kela drug reimbursment
Lenvatinib
+∞
29.3
28
*
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
24.1
28.4
40
17
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
22.1
28.3
41
19
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
28.2
27
*
A07AA11
ATC
rifaximin; oral
+∞
28.2
27
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.3
27.9
76
126
L04AA06
ATC
mycophenolic acid; systemic
10.0
27.8
56
58
ZX090
NOMESCO Finland
Other technic of radiotherapy
147.6
27.7
29
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.5
27.2
232
1012
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
27.0
27.1
37
14
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
26.8
255
1179
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
98.5
26.7
29
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.5
26.5
70
112
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
52.6
26.3
31
6
K76.9
ICD-10 Finland
Liver disease, unspecified
8.1
25.6
58
74
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
50.9
25.3
30
6
I81
ICD-10 Finland
Portal vein thrombosis
36.3
25.3
32
9
R4110
NOMESCO Finland
Physiotherapy
2.0
25.2
385
2192
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
+∞
25.1
24
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
25.1
24
*
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
25.0
550
3575
PJA12
NOMESCO Finland
Sentinel node biopsy
254.0
24.7
25
*
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
254.0
24.7
25
*
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
20.4
24.4
36
18
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
+∞
24.0
23
*
8000/3-C23.9
ICD-O-3
Neoplasm, malignant of gallbladder
+∞
24.0
23
*
8140/3-C24.9
ICD-O-3
Adenocarcinoma, NOS, of billiary tract, NOS
+∞
24.0
23
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
24.0
23
*
J01MA02
ATC
ciprofloxacin; systemic
1.8
23.8
593
4003
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
19.9
23.5
35
18
N02AA01
ATC
morphine; systemic, rectal
11.3
23.4
44
40
C03CA01
ATC
furosemide; systemic
1.8
23.2
656
4594
JJA20
NOMESCO Finland
Open biopsy of liver
54.9
23.1
27
5
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
23.0
22
*
176
Kela drug reimbursment
Regorafenib
+∞
23.0
22
*
L01EX08
ATC
lenvatinib; oral
+∞
23.0
22
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
22.9
304
1627
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
84.7
22.7
25
*
TJA10
NOMESCO Finland
Laparocentesis
233.2
22.7
23
*
K92.0
ICD-10 Finland
Haematemesis
4.6
22.3
79
179
L04AD01
ATC
ciclosporin; systemic
8.2
22.3
50
63
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
21.7
22.2
32
15
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
11.4
22.0
41
37
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
16.2
21.9
35
22
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
222.9
21.6
22
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
116.6
21.6
23
*
A98
ICPC
Health maint/preventive medicine
0.6
21.3
891
10757
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
21.0
481
3131
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
+∞
20.9
20
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
20.9
20
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
20.9
20
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
37.7
20.8
26
7
WF003
NOMESCO Finland
Adjuvant radiotherapy
212.7
20.6
21
*
Y77
ICPC
Malignant neoplasm prostate
212.7
20.6
21
*
115
Kela drug reimbursment
Breast cancer
+∞
19.8
19
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
+∞
19.8
19
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
202.4
19.6
20
*
JJ5AT
NOMESCO Finland
NA
202.4
19.6
20
*
UJK12
NOMESCO Finland
Peroral cholangioscopy
15.8
19.3
31
20
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
19.2
433
2787
B18.2
ICD-10 Finland
Chronic viral hepatitis C
15.0
18.9
31
21
A10BA02
ATC
metformin; oral
1.7
18.9
523
3578
UJF32
NOMESCO Finland
Coloscopy
1.8
18.8
366
2241
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
+∞
18.8
18
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
192.2
18.6
19
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.4
18.1
90
277
KCD02
NOMESCO Finland
Transurethral resection of bladder
12.1
17.8
32
27
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
17.7
17
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
17.7
17
*
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
17.7
17
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
17.7
17
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
29.1
17.4
23
8
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.8
17.3
75
206
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
42.5
17.3
21
5
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
6.9
17.0
42
62
D13.4
ICD-10 Finland
Benign neoplasm: Liver
17.6
16.9
26
15
A10BB12
ATC
glimepiride; oral
2.2
16.9
193
962
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
64.0
16.8
19
*
XX4BW
NOMESCO Finland
NA
64.0
16.8
19
*
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
16.7
16
*
A10AE04
ATC
insulin glargine; parenteral
2.1
16.1
185
922
SPAT1262
SPAT
Handing over of treatment supplies
1.8
16.0
302
1822
WX004
NOMESCO Finland
Patient-controlled sedation
15.8
15.7
25
16
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
15.6
15
*
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
15.6
15
*
WX002
NOMESCO Finland
Sedation and analgesia
1.8
15.6
278
1641
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
85.9
15.6
17
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
8.6
15.5
33
39
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.3
15.4
148
680
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
5.4
15.2
45
85
K72.1
ICD-10 Finland
Chronic hepatic failure
23.6
15.1
21
9
XQ902
NOMESCO Finland
Other photography
14.1
15.0
25
18
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
15.0
251
1448
A41.8
ICD-10 Finland
Other specified sepsis
5.0
15.0
48
99
D97
ICPC
Liver disease NOS
15.2
14.9
24
16
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
12.6
14.9
26
21
WX892
NOMESCO Finland
Monitored bed care
2.4
14.7
131
580
PC2SC
NOMESCO Finland
Liver angiography with X-ray
+∞
14.6
14
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
14.6
14
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
14.6
14
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
14.6
14
*
L01XE21
ATC
[U] regorafenib; oral
+∞
14.6
14
*
C10AA05
ATC
atorvastatin; oral
0.6
14.6
334
4790
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
151.3
14.5
15
*
TK800
NOMESCO Finland
Hemodialysis
4.1
14.0
54
135
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.8
13.7
45
96
369
Kela drug reimbursment
Regorafenib
+∞
13.6
13
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
13.6
13
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
13.6
13
*
C24.01
ICD-10 Finland
Cystic duct
+∞
13.6
13
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
13.6
13
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
13.6
13
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
13.6
13
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
141.1
13.5
14
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
141.1
13.5
14
*
A10BH01
ATC
sitagliptin; oral
2.0
13.4
176
925
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
40.4
13.2
16
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
19.2
12.9
19
10
JDE00
NOMESCO Finland
Gastrojejunostomy
50.4
12.8
15
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.3
12.8
33
53
8010/3-C22.0
ICD-O-3
Carcinoma, NOS, of liver
+∞
12.5
12
*
8140/3-C22.0
ICD-O-3
Adenocarcinoma, NOS, of liver
+∞
12.5
12
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
12.5
12
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
12.5
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
12.5
12
*
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
+∞
12.5
12
*
JKC30
NOMESCO Finland
Partial excision of bile duct and anastomosis to jejunum
+∞
12.5
12
*
1552X
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]
+∞
12.5
12
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
12.5
12
*
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
12.5
79
290
ZX080
NOMESCO Finland
Image guided radiotherapy
131.0
12.4
13
*
D76
ICPC
Malignant neoplasm pancreas
131.0
12.4
13
*
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
12.4
88
1740
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.1
12.2
47
118
SPAT1109
SPAT
Analgesia with portable analgesic pump
12.5
12.1
21
17
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.4
12.1
43
100
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
8.7
12.0
25
29
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
12.0
191
1078
B01AB04
ATC
dalteparin; parenteral
2.7
12.0
84
328
SPAT1053
SPAT
Memory test
0.5
11.8
110
2006
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.5
11.7
41
94
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
3.2
11.7
62
202
SPAT1255
SPAT
Intravenous administration of medicine
2.3
11.6
107
480
ZXC40
NOMESCO Finland
Use of ultrasound
11.2
11.5
21
19
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
11.5
11
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
11.5
11
*
JJB53
NOMESCO Finland
Excision of segments IV,V, VI, VII and VIII of liver
+∞
11.5
11
*
L01XE29
ATC
[U] lenvatinib; oral
+∞
11.5
11
*
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
+∞
11.5
11
*
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
+∞
11.5
11
*
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
11.5
11
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
11.5
11
*
L04AA10
ATC
sirolimus; oral
+∞
11.5
11
*
N06DX01
ATC
memantine; oral
0.4
11.3
35
952
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
11.9
11.3
20
17
B01AF01
ATC
rivaroxaban; oral
0.4
11.3
48
1145
ZX050
NOMESCO Finland
Stereotactic radiotherapy
35.3
11.3
14
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
11.2
369
2576
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.9
11.2
69
248
K75.0
ICD-10 Finland
Abscess of liver
25.2
11.1
15
6
WX882
NOMESCO Finland
High dependency care
3.2
11.1
57
182
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.2
11.1
33
64
WW200
SPAT
NA
0.3
11.0
19
682
K92.1
ICD-10 Finland
Melaena
2.3
10.9
105
481
R83
ICPC
Respiratory infection other
0.4
10.8
42
1037
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
21.6
10.7
15
7
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
14.3
10.5
17
12
HAC20
NOMESCO Finland
Total mastectomy
110.7
10.4
11
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
10.4
10
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
10.4
10
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
10.4
10
*
JJA43
NOMESCO Finland
Destruction of lesion of liver
+∞
10.4
10
*
JJB20
NOMESCO Finland
Excision of single segment of liver
+∞
10.4
10
*
XF612
NOMESCO Finland
Measurement of central venous pressure
23.5
10.2
14
6
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
10.2
188
2869
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
4.0
10.1
39
99
T90
ICPC
Diabetes non-insulin dependent
1.5
10.0
355
2510
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
2.3
10.0
89
395
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
40.3
10.0
12
*
HA1AA
NOMESCO Finland
X-ray mammography
4.6
9.9
33
73
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
16.8
9.9
15
9
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.0
9.8
54
182
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.7
9.8
27
48
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.4
9.8
35
893
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
9.7
109
537
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
9.7
78
1490
NK6AN
NOMESCO Finland
Total body bone isotope imaging
13.5
9.7
16
12
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
10.1
9.5
18
18
P20
ICPC
Memory disturbance
0.5
9.5
87
1599
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.4
9.4
80
347
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
100.6
9.4
10
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
17.6
9.4
14
8
L01BC04
ATC
carmofur; oral
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
9.4
9
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
9.4
9
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
9.4
9
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
C10AA07
ATC
rosuvastatin; oral
0.6
9.4
151
2385
RS220
NOMESCO Finland
NA
5.9
9.4
25
43
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
21.8
9.3
13
6
ZZR00
NOMESCO Finland
Flap of skin
9.1
9.0
18
20
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.6
9.0
62
241
JK3MB
NOMESCO Finland
Postoperative cholangiography
36.9
9.0
11
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
9.0
97
470
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
8.8
140
788
J94.8
ICD-10 Finland
Other specified pleural conditions
3.8
8.7
35
93
205
Kela drug reimbursment
Chronic hypertension
1.4
8.7
542
4282
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.2
8.7
88
415
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
8.7
97
479
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.0
8.5
26
53
N05CF01
ATC
zopiclone; oral
1.4
8.5
464
3575
L03
ICPC
Low back symptom/complaint
0.6
8.5
114
1886
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
90.5
8.4
9
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
90.5
8.4
9
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
8.4
100
1707
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
8.3
8
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
8.3
8
*
L01EX05
ATC
regorafenib; oral
+∞
8.3
8
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
8.3
8
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
8.3
8
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
8.3
8
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
8.3
8
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
8.3
8
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.6
8.3
27
59
K70.4
ICD-10 Finland
Alcoholic hepatic failure
8.6
8.3
17
20
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
8.3
121
664
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.5
8.2
20
31
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
33.5
8.1
10
*
L02BA01
ATC
tamoxifen; oral
33.5
8.1
10
*
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
9.0
8.0
16
18
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
5.9
8.0
21
36
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.7
7.9
150
896
L04AX01
ATC
azathioprine; systemic
2.5
7.9
58
234
K70.1
ICD-10 Finland
Alcoholic hepatitis
6.6
7.9
19
29
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
6.1
7.8
20
33
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.8
7.8
140
821
WX704
NOMESCO Finland
Intubation
2.1
7.8
84
410
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
45.2
7.7
9
*
K76.89
ICD-10 Finland
Other specified diseases of liver
15.1
7.7
12
8
K85.8
ICD-10 Finland
Other acute pancreatitis
6.4
7.7
19
30
N05AX08
ATC
risperidone; systemic
0.5
7.6
44
939
207
Kela drug reimbursment
Chronic arrhythmias
0.6
7.6
122
1935
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
8.1
7.6
16
20
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
6.7
7.6
18
27
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
25.1
7.6
10
*
ZX121
NOMESCO Finland
Central venous catheter
25.1
7.6
10
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
7.5
129
746
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
2.7
7.5
48
179
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
80.4
7.4
8
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
80.4
7.4
8
*
D13
ICPC
Jaundice
80.4
7.4
8
*
A10AE05
ATC
insulin detemir; parenteral
2.0
7.4
90
460
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.4
411
3161
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
7.3
292
3862
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.5
7.3
57
237
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
+∞
7.3
7
*
QX9VV
NOMESCO Finland
NA
+∞
7.3
7
*
8140/3-C22.1
ICD-O-3
Adenocarcinoma, NOS, of intrahepatic bile duct
+∞
7.3
7
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
7.3
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
7.3
7
*
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
7.3
7
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
7.3
7
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
7.3
7
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
7.3
7
*
1551A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Intrahepatic bile ducts
+∞
7.3
7
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
7.3
7
*
6603
FHL
Delete a block
+∞
7.3
7
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
7.3
7
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
7.3
7
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
7.3
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.3
7
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
7.3
7
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
K72.9
ICD-10 Finland
Hepatic failure, unspecified
6.9
7.3
17
25
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.8
7.2
44
161
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.8
7.2
46
170
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
30.1
7.1
9
*
K51.8
ICD-10 Finland
Other ulcerative colitis
4.4
7.1
24
55
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
20.1
7.1
10
5
K51.5
ICD-10 Finland
Left sided colitis
3.1
7.1
36
117
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
7.1
165
1049
L15
ICPC
Knee symptom/complaint
0.6
7.1
105
1697
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
10.1
7.0
13
13
K81.0
ICD-10 Finland
Acute cholecystitis
2.8
7.0
43
159
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
4.9
7.0
21
43
R10.0
ICD-10 Finland
Acute abdomen
2.8
7.0
41
147
K76.7
ICD-10 Finland
Hepatorenal syndrome
13.8
6.9
11
8
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
6.8
218
3006
C10AX09
ATC
ezetimibe; oral
0.5
6.8
54
1039
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
6.8
232
1617
JFB30
NOMESCO Finland
Right hemicolectomy
6.7
6.8
16
24
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.6
6.8
46
180
ZX112
NOMESCO Finland
Subcutaneous
5.3
6.8
19
36
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.7
6.8
18
32
K70.0
ICD-10 Finland
Alcoholic fatty liver
4.7
6.7
21
45
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
6.6
57
253
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
12.3
6.6
11
9
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.5
6.5
49
201
WVA20
NOMESCO Finland
Medicine administration
3.5
6.5
28
81
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
6.5
50
210
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.7
6.5
197
2739
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
70.1
6.4
7
*
V03AF03
ATC
calcium folinate; systemic
70.1
6.4
7
*
2BB01
NOMESCO Finland
NA
70.1
6.4
7
*
C90.0
ICD-10 Finland
Multiple myeloma
70.1
6.4
7
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.4
6.4
50
212
XW000
NOMESCO Finland
Bone marrow biopsy
2.5
6.4
46
186
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
14.4
6.4
10
7
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
14.4
6.4
10
7
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.7
6.4
255
3386
M79.6
ICD-10 Finland
Pain in limb
0.7
6.4
235
3160
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.4
6.3
32
716
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
6.0
6.3
16
27
L02BG04
ATC
letrozole; oral
18.1
6.3
9
5
A04AA03
ATC
tropisetron; systemic
+∞
6.3
6
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.3
6
*
8163/3-C24.1
ICD-O-3
Pancreatobiliary type carcinoma of ampulla of Vater
+∞
6.3
6
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
6.3
6
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.3
6
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
6.3
6
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
6.3
6
*
C22.4
ICD-10 Finland
Malignant neoplasm: Other sarcomas of liver
+∞
6.3
6
*
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
6.3
6
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
6.3
6
*
JJ2CT
NOMESCO Finland
Biopsy of liver with CT guidance
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
6.3
6
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
6.3
6
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
6.3
6
*
C22.3
ICD-10 Finland
Malignant neoplasm: Angiosarcoma of liver
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
6.3
6
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
6.3
6
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
26.8
6.2
8
*
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
7.0
6.2
14
20
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.3
6.2
54
242
ZX108
NOMESCO Finland
Inhalation
6.3
6.2
15
24
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
6.3
6.2
15
24
R03DC03
ATC
montelukast; oral
0.5
6.1
57
1046
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
3.5
6.1
26
75
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
0.5
6.1
41
828
B03XA02
ATC
darbepoetin alfa; parenteral
3.1
6.1
30
97
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
3.0
6.0
32
109
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1284
989
27.10
307.65
5.5
1.4
31.1
4.1
ug/l
3.70
1158
750
893
1342
10.06
307.65
5.4
1.9
0.2
0.2
g/l
12.91
843
1202
435
373
14.05
307.65
4.5
2.4
41.9
36.1
umol/l
1.18
379
313
840
369
34.68
307.65
5.2
1.8
2202.1
89.6
u/ml
1.89
768
293
891
1685
7.86
307.65
10.1
2.3
28.0
8.5
umol/l
17.49
836
1456
561
189
38.56
307.65
5.3
1.8
739.8
90.8
u/ml
3.72
536
173
209
84
27.19
301.63
1.5
1.2
—
—
—
0
0
261
196
14.84
282.20
1.3
1.1
1.7
1.5
g/l
3.35
246
168
144
24
63.81
260.45
3.6
2.6
—
—
—
0
0
656
1677
5.02
244.77
10.5
6.3
8.4
11.6
mmol/l
20.68
634
1570
1516
7431
3.88
221.84
14.4
3.8
31.3
35.0
g/l
94.90
1461
6761
1613
8351
3.91
214.53
25.8
3.8
25.9
12.6
umol/l
23.93
1583
7794
1224
5382
3.63
208.21
6.4
2.3
58.0
60.1
u/l
0.36
1179
4917
1012
4020
3.64
200.12
13.3
3.5
76.7
82.5
%
10.01
989
3901
1130
4911
3.48
192.13
11.5
2.5
67.4
38.7
u/l
6.81
1096
4627
761
2601
3.83
187.16
5.2
2.5
0.8
0.8
mmol/l
24.07
733
2362
498
1394
4.26
160.16
6.2
2.2
41.9
38.1
u/l
0.27
454
1155
1435
7823
3.11
156.07
16.3
11.2
1.3
1.4
inr
5.06
369
2152
102
43
24.74
143.64
2.1
2.7
7869.3
416.6
e6/l
0.52
75
33
140
119
12.44
139.27
1.6
1.2
—
—
—
0
0
88
36
25.35
125.19
2.0
2.4
1668.9
59007.6
e6/l
0.56
54
20
826
3695
2.89
122.23
3.9
2.2
—
—
—
0
0
1254
7216
2.56
108.78
6.9
3.7
—
—
—
0
0
447
1507
3.42
106.51
2.2
1.7
1.6
1.6
%
0.23
389
1267
201
380
5.69
102.31
3.8
2.3
2.9
3.5
g/l
4.04
195
356
598
2461
2.91
100.69
2.6
2.6
23.8
22.4
%
1.13
549
2049
349
1040
3.76
100.09
2.2
2.1
12.6
10.9
g/l
6.51
314
940
149
218
7.23
97.68
8.1
5.1
1125.6
694.4
iu/ml
0.46
46
25
207
432
5.15
94.25
1.6
1.4
173.7
287.5
ug/g
10.19
126
263
608
2638
2.75
91.62
2.6
2.5
2.3
2.3
g/l
0.11
573
2415
639
2866
2.68
89.99
2.6
2.5
12.5
12.7
umol/l
0.33
612
2611
110
124
9.25
89.60
1.4
1.3
149.0
147.1
titre
0.01
20
21
1401
8987
2.36
88.79
19.6
6.0
4.3
4.5
e9/l
1.70
1279
7678
171
332
5.47
84.31
1.2
1.3
—
—
—
0
0
187
406
4.91
81.09
6.2
2.8
1.6
1.7
mg/l
0.79
173
356
535
2324
2.68
79.19
9.6
5.9
104.8
104.3
mmol/l
1.51
528
2254
464
1893
2.80
77.48
3.7
2.6
257.6
236.7
u/l
0.99
448
1745
134
227
6.20
76.18
1.2
1.2
—
—
—
0
0
615
2910
2.50
75.87
2.8
1.9
31.5
30.1
s
4.73
603
2810
127
206
6.46
75.37
1.3
1.2
359.7
293.7
u/ml
1.03
86
124
56
27
21.22
74.39
1.1
1.4
50.3
25.5
g/l
0.37
36
22
64
42
15.63
73.57
1.7
1.5
10.7
14.9
g/l
1.68
46
29
126
213
6.19
71.75
1.3
1.4
120.2
112.3
u/ml
0.42
13
37
522
2348
2.57
71.20
6.9
5.1
1.0
1.0
mmol/l
0.16
493
2133
287
955
3.28
68.28
10.6
9.1
—
—
—
0
0
132
247
5.60
67.59
1.3
1.3
—
18.3
—
0
7
1227
8008
2.10
67.25
9.1
5.2
1.2
1.2
mmol/l
17.19
1172
7066
1318
8850
2.10
66.74
10.2
5.6
1.2
1.2
mmol/l
17.33
1122
7402
69
5
142.06
65.24
3.3
5.0
486.5
877.8
u/l
—
61
5
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
217
625
3.72
64.49
2.8
2.8
0.3
0.3
u/ml
1.56
109
369
75
79
9.77
64.15
1.1
1.0
—
—
—
0
0
1423
9923
2.08
63.95
10.8
3.0
217.3
51.5
u/l
80.14
1354
8981
65
57
11.70
63.05
31.8
26.2
130.0
126.8
ug/l
0.10
52
46
324
1216
2.93
62.37
1.7
1.5
—
—
—
0
0
285
1012
3.06
60.48
9.6
6.8
24.1
24.8
mmol/l
2.62
279
1001
41
15
27.80
60.27
2.5
1.1
52.0
19.8
u/ml
1.71
41
15
307
1148
2.92
59.36
10.2
8.1
95.2
93.3
%
8.69
307
1142
412
1808
2.55
58.18
9.6
6.7
116.8
121.9
g/l
5.12
400
1739
904
5492
2.04
57.73
7.2
2.1
2.3
2.3
mmol/l
4.25
848
4519
141
323
4.58
57.03
2.4
1.6
149.7
22.3
u/ml
3.06
135
307
178
487
3.87
56.85
1.8
1.7
—
—
—
0
0
439
2016
2.44
56.07
9.2
6.4
96.9
94.7
%
12.66
427
1933
115
226
5.30
55.73
6.5
6.2
11.9
12.3
mg/l
0.24
105
206
469
2229
2.38
55.42
9.0
6.2
5.0
5.1
kpa
0.67
451
2117
469
2229
2.38
55.42
9.0
6.2
13.1
11.4
kpa
11.96
449
2113
467
2220
2.37
55.13
9.0
6.2
0.4
1.2
mmol/l
4.68
381
1692
1458
10567
1.98
55.05
10.9
4.4
7.4
6.9
mmol/l
10.46
1413
9887
604
3237
2.16
53.16
7.5
2.2
2.5
2.4
mmol/l
18.33
569
2757
289
1156
2.71
48.80
10.6
8.0
0.6
0.7
%
1.46
289
1147
91
164
5.73
48.42
2.7
2.6
209.8
299.1
u/ml
—
5
14
223
781
3.05
48.14
2.2
1.7
2.3
1.7
ug/l
0.30
211
666
364
1638
2.44
48.09
8.9
6.0
1.8
1.4
mmol/l
2.97
348
1563
43
32
13.67
45.99
1.1
1.0
—
—
—
0
0
283
1165
2.62
44.98
10.5
7.9
1.3
1.4
%
0.12
283
1157
1654
12942
1.92
44.78
28.0
5.3
173.9
77.7
u/l
92.51
1615
11904
243
951
2.73
42.62
11.2
8.3
23.8
24.3
mmol/l
1.68
234
861
231
907
2.71
40.19
4.7
3.7
23.1
24.1
mmol/l
4.19
220
788
765
4874
1.84
38.92
3.7
3.0
0.9
0.5
e6/l
2.98
615
3690
56
78
7.33
38.20
1.1
1.2
—
—
—
0
0
1088
7734
1.75
37.88
7.5
5.6
22.7
26.1
%
18.85
1023
7040
374
1889
2.16
36.99
4.6
3.4
1.1
1.9
mmol/l
3.85
287
1498
27
12
22.75
36.76
1.2
1.3
1.7
0.8
ml/s/173m2
—
21
7
373
1893
2.15
36.40
4.5
3.4
5.5
5.8
kpa
7.58
363
1817
66
118
5.72
35.41
1.1
1.0
280.5
285.0
mg/l
0.14
56
103
541
3197
1.90
34.23
2.0
1.8
—
—
—
0
0
484
2758
1.95
34.17
3.2
2.9
2.2
2.1
e6/l
0.06
289
1531
1052
7649
1.67
31.91
7.3
5.4
61.3
58.6
%
8.95
991
7008
351
1855
2.05
30.42
4.5
3.3
—
—
—
0
0
249
1161
2.28
29.68
1.7
1.5
—
—
—
0
0
1394
16645
0.61
29.53
5.1
4.8
4.2
4.4
mmol/l
6.06
1239
15165
1449
17121
0.61
29.06
5.3
5.4
2.4
2.6
mmol/l
5.07
1270
15525
1383
16471
0.62
27.85
5.0
4.8
1.3
1.4
mmol/l
14.82
1212
14878
57
113
5.14
27.35
1.0
1.0
—
—
—
0
0
585
3780
1.73
26.59
3.1
2.4
5.7
4.7
e6/l
1.41
542
3279
1429
16802
0.62
25.92
5.1
5.0
6.5
6.1
mmol/l
13.45
1265
15034
483
2982
1.78
25.66
3.1
2.7
1.1
1.3
e6/l
0.49
288
1744
385
2235
1.86
24.99
2.0
1.8
—
—
—
0
0
382
2239
1.84
23.97
2.0
1.7
—
—
—
0
0
1391
11331
1.55
23.15
5.1
4.5
1013.4
2724.6
e6/l
1.09
28
204
424
2602
1.77
22.73
1.6
1.3
3.6
2.8
g/l
6.55
315
1468
40
69
5.88
22.29
1.7
1.2
—
—
—
0
0
264
1404
1.99
22.15
5.1
3.1
1.2
1.2
mmol/l
2.76
245
1189
72
202
3.64
22.13
2.9
2.9
2.3
1.6
%
0.54
56
147
1358
15941
0.65
21.72
4.6
4.3
1.4
1.3
mmol/l
2.91
1195
14270
678
4771
1.59
21.30
2.6
2.3
3.5
3.0
mg/l
4.87
593
4003
23
23
10.09
20.28
1.3
1.0
—
—
—
0
0
18
12
15.11
20.21
1.2
1.2
—
—
—
0
0
1407
16238
0.67
18.80
8.6
6.6
43.5
41.2
mmol/mol
10.94
1273
14830
75
241
3.18
18.69
1.2
1.3
—
—
—
0
0
240
1311
1.92
18.53
7.6
6.2
23.6
24.5
mmol/l
2.63
225
1224
68
210
3.30
18.09
1.3
1.2
—
—
—
0
0
282
4588
0.56
18.08
2.1
1.6
1.5
1.3
mmol/l
2.88
250
3805
463
3089
1.62
17.73
19.9
29.9
1.5
1.5
inr
0.05
53
417
53
141
3.82
17.63
1.1
1.2
52.5
54.0
u/l
0.07
40
95
251
1418
1.86
17.45
4.0
2.5
66.1
61.4
ml/min/173m2
0.87
114
580
169
845
2.08
16.74
6.5
4.2
1.7
1.6
%
0.53
158
803
101
413
2.51
16.10
8.5
5.8
105.8
105.2
mmol/l
0.85
90
375
35
74
4.79
15.66
2.0
1.4
18.9
86.8
u/l
—
9
19
1335
15369
0.70
15.64
4.6
4.4
2.4
2.1
mu/l
1.87
1179
13708
523
7109
0.66
15.12
3.6
3.8
22.9
24.4
%
1.14
234
3517
846
6600
1.44
15.04
3.3
2.8
214.6
146.4
ug/l
6.39
782
5976
261
1579
1.73
14.35
4.2
2.9
4.7
4.5
kpa
0.99
253
1508
339
4915
0.64
12.92
2.7
2.8
0.8
0.8
ug/l
0.05
229
3441
83
344
2.46
12.91
1.7
1.4
—
—
—
0
0
85
359
2.42
12.70
1.6
1.4
—
—
—
0
0
114
550
2.13
12.43
1.3
1.2
—
—
—
0
0
69
272
2.58
11.94
3.3
3.1
59.1
59.7
%
0.12
69
272
66
257
2.61
11.71
1.6
1.4
—
—
—
0
0
1706
18555
0.71
11.56
55.4
21.2
7.3
6.9
e9/l
7.20
1648
17804
1706
18553
0.71
11.53
55.8
21.3
122.3
135.7
g/l
181.54
1661
18125
1706
18552
0.71
11.51
55.4
21.2
4.1
4.5
e12/l
118.37
1646
17794
78
332
2.40
11.49
1.6
1.6
—
—
—
0
0
1706
18547
0.72
11.43
55.4
21.2
225.0
237.5
e9/l
7.19
1650
17867
38
109
3.53
11.42
1.7
1.5
—
—
—
0
0
218
1343
1.69
11.17
2.8
1.8
411.3
363.8
nmol/l
2.23
201
1200
33
89
3.75
10.85
1.6
1.5
5.2
7.0
u/l
0.23
22
39
48
165
2.95
10.78
2.7
2.6
—
—
—
0
0
1066
12360
0.75
10.49
3.9
3.6
14.9
15.0
pmol/l
0.51
935
10981
12
12
10.05
10.44
1.0
1.1
—
—
—
0
0
149
2514
0.57
10.35
1.2
1.3
50.7
41.5
iu/ml
0.18
56
761
715
8768
0.74
10.27
4.1
4.0
2.2
2.7
ug/l
0.52
591
7810
340
2374
1.50
10.22
2.5
2.1
2.0
1.7
%
2.59
307
2054
11
10
11.05
10.16
1.4
1.0
—
—
—
0
0
133
735
1.86
9.91
4.1
3.7
1.8
1.5
mmol/l
1.23
133
718
26
63
4.16
9.89
1.8
1.5
—
—
—
0
0
42
143
2.97
9.62
3.1
2.9
64.4
58.7
%
0.70
24
89
49
183
2.71
9.49
1.5
1.5
29200.5
61541.4
e6/l
0.45
31
108
24
57
4.24
9.38
2.5
2.5
—
—
—
0
0
17
30
5.70
9.27
1.2
1.1
—
—
—
0
0
50
192
2.64
9.19
1.4
1.2
—
—
—
0
0
62
265
2.38
9.11
3.0
3.0
4.3
4.7
e9/l
0.31
62
265
191
1202
1.64
9.02
1.8
1.6
—
—
—
0
0
48
185
2.63
8.77
1.5
1.2
—
—
—
0
0
48
186
2.61
8.68
1.5
1.2
—
—
—
0
0
51
205
2.52
8.57
1.6
1.5
683.6
1559.4
e6/l
3.24
41
146
48
189
2.57
8.42
1.5
1.2
—
—
—
0
0
84
421
2.03
8.38
2.5
2.4
14.7
16.4
%
1.99
32
229
47
184
2.59
8.34
1.5
1.2
—
—
—
0
0
150
2376
0.61
8.08
1.2
1.2
11.1
16.8
u/ml
0.43
54
881
47
187
2.54
8.08
1.5
1.2
—
—
—
0
0
230
1565
1.52
7.78
2.1
1.6
65.7
66.5
g/l
0.66
206
1378
149
920
1.66
7.61
1.6
1.6
1.3
1.5
g/l
1.55
120
776
71
348
2.07
7.55
1.4
1.2
—
—
—
0
0
165
1050
1.61
7.48
3.7
3.1
23.8
25.1
mmol/l
4.31
159
1007
43
171
2.54
7.43
1.7
1.5
—
—
—
0
0
51
222
2.33
7.26
1.6
1.4
—
—
—
0
0
30
101
3.00
7.08
1.2
1.3
—
—
—
0
0
77
403
1.94
6.86
1.4
1.5
—
—
—
0
0
30
104
2.91
6.74
1.2
1.3
—
—
—
0
0
89
492
1.84
6.72
1.5
1.3
21.0
16.9
iu/ml
—
5
11
39
879
0.43
6.56
1.7
1.9
—
—
—
0
0
129
799
1.65
6.54
1.9
1.7
—
—
—
0
0
146
933
1.60
6.53
2.9
2.6
1.1
1.2
%
0.54
146
926
155
1014
1.57
6.29
3.1
2.5
0.9
0.3
e6/l
1.31
155
992
31
114
2.74
6.28
1.7
1.5
11.5
14.9
umol/l
2.44
31
103
1680
17913
0.79
6.26
31.7
9.3
41.0
25.5
u/l
65.29
1644
17021
1445
15668
0.80
6.22
38.0
13.6
77.2
73.5
ml/min/173m2
8.18
1297
12638
23
73
3.17
6.02
1.3
1.2
—
—
—
0
0
23
73
3.17
6.02
1.3
1.2
—
—
—
0
0
443
3533
1.31
5.92
2.2
1.6
2.9
1.3
mg/l
5.77
368
2755
79
440
1.82
5.87
1.5
1.3
—
—
—
0
0
79
440
1.82
5.87
1.5
1.3
—
—
—
0
0
55
271
2.05
5.84
1.7
1.3
—
—
—
0
0
19
55
3.47
5.73
2.2
2.4
—
—
—
0
0
879
7651
1.24
5.65
4.3
4.1
39.3
96.5
ng/l
1.53
735
5854
50
243
2.08
5.53
1.6
1.3
—
—
—
0
0
1696
17990
0.80
5.49
44.5
18.0
4.0
4.0
mmol/l
1.26
1652
17412
36
153
2.37
5.48
1.4
1.3
—
—
—
0
0
34
141
2.43
5.46
1.4
1.3
—
—
—
0
0
483
3936
1.29
5.45
3.9
4.2
522.7
511.7
ng/l
0.02
412
3382
102
628
1.65
5.35
4.4
4.0
4.0
3.9
mmol/l
0.13
97
582
116
739
1.60
5.31
1.7
1.7
—
—
—
0
0
32
131
2.46
5.29
1.7
1.4
—
—
—
0
0
11
22
5.02
5.26
1.3
3.5
—
—
—
0
0
64
346
1.87
5.25
1.5
1.5
—
—
—
0
0
5
0
+∞
5.21
1.0
0.0
16.8
—
umol/l
—
5
0
19
59
3.24
5.17
1.3
1.2
19.5
30.8
u/l
0.75
12
40
44
210
2.12
5.12
1.5
1.3
—
—
—
0
0
1696
17951
0.81
5.10
44.4
17.9
137.9
139.7
mmol/l
93.95
1655
17398
8
6
13.37
5.08
5.3
3.2
—
—
—
0
0
19
60
3.18
5.04
1.3
2.3
16.8
14.3
%
—
6
30
46
226
2.06
4.97
1.6
1.3
—
—
—
0
0
97
605
1.63
4.87
2.2
2.8
—
—
—
0
0
40
189
2.14
4.79
2.1
2.3
859.2
625.1
ml
1.77
21
113
28
113
2.50
4.79
1.4
1.1
—
—
—
0
0
712
8157
0.82
4.69
2.6
2.3
—
—
—
0
0
7
5
14.04
4.57
1.4
1.2
2350.4
17.6
u/l
—
7
5
9
11
8.21
4.56
1.1
1.1
—
—
—
0
0
23
87
2.66
4.49
1.5
1.3
—
—
—
0
0
23
88
2.63
4.39
1.5
1.3
—
—
—
0
0
89
577
1.56
3.87
2.4
2.3
130.7
92.0
ug/min
0.42
50
342
46
251
1.85
3.76
1.3
1.5
10.5
7.1
u/l
1.47
26
205
739
6540
1.19
3.64
3.1
3.2
1395.0
1785.3
ng/l
1.38
648
5643
27
124
2.19
3.54
1.3
1.2
—
—
—
0
0
27
124
2.19
3.54
1.3
1.2
—
—
—
0
0
27
124
2.19
3.54
1.3
1.2
—
—
—
0
0
75
478
1.59
3.53
4.4
3.0
8.4
7.9
kpa
1.68
67
445
37
194
1.92
3.44
1.2
1.2
191.3
181.3
miu/ml
—
6
63
172
1301
1.35
3.34
3.9
3.6
4.9
5.2
kpa
4.50
156
1189
18
71
2.55
3.29
2.1
1.4
563.4
812.8
e6/l
—
8
31
164
1235
1.35
3.29
3.9
3.6
1.8
1.9
mmol/l
0.11
110
882
251
2006
1.28
3.29
3.2
3.2
203.8
256.7
ng/l
1.74
234
1853
23
103
2.25
3.22
1.5
1.3
—
—
—
0
0
201
1583
1.29
2.97
2.7
2.2
225.0
168.7
ug/g
0.79
167
1243
15
58
2.60
2.87
2.4
3.4
26.3
37.9
mu/l
0.29
15
51
15
58
2.60
2.87
1.7
1.4
52.3
90.4
umol/l
—
7
38
557
4899
1.18
2.87
3.7
2.6
3151.2
6883.5
umol/l
1.41
488
4121
185
2325
0.78
2.74
4.1
4.9
33.2
33.1
%
0.04
127
1506
39
639
0.60
2.56
1.1
1.1
—
—
—
0
0
12
44
2.74
2.54
1.3
1.2
—
—
—
0
0
12
44
2.74
2.54
1.3
1.2
—
—
—
0
0
12
44
2.74
2.54
1.3
1.2
—
—
—
0
0
15
63
2.39
2.46
1.3
1.2
—
—
—
0
0
15
63
2.39
2.46
1.3
1.2
—
—
—
0
0
15
63
2.39
2.46
1.3
1.2
—
—
—
0
0
15
63
2.39
2.46
1.3
1.2
—
—
—
0
0
13
51
2.56
2.44
1.3
1.3
—
—
—
0
0
56
835
0.66
2.44
1.2
1.3
338.9
259.0
u/ml
0.32
48
766
6
13
4.62
2.27
1.0
1.3
—
—
—
0
0
5
9
5.56
2.21
1.2
4.2
—
—
—
0
0
16
74
2.17
2.14
1.1
1.1
106.5
89.0
u/l
0.28
11
56
16
74
2.17
2.14
1.1
1.1
54.3
29.5
u/l
0.42
11
53
177
1437
1.25
2.11
3.4
3.7
83.5
97.4
ng/l
1.97
163
1200
31
183
1.70
2.08
1.2
1.3
—
—
—
0
0
36
566
0.63
2.05
1.4
1.7
—
—
—
0
0
741
6801
1.13
2.04
2.7
2.2
73.6
78.4
nmol/l
4.17
679
5873
5
146
0.34
2.01
1.2
1.1
—
87.0
—
0
7
5
147
0.34
2.00
1.2
1.1
—
62.7
—
0
15
14
64
2.19
1.94
1.9
1.5
0.2
0.2
e9/l
0.12
14
58
75
548
1.38
1.93
2.3
1.4
0.0
0.0
g/l
0.00
61
489
243
2060
1.20
1.92
2.3
2.4
6.0
7.6
ug/l
0.65
212
1764
519
4673
1.14
1.92
4.9
4.0
0.0
0.0
estimate
0.50
171
1367
21
113
1.87
1.91
1.1
1.2
14.1
12.1
mmol/l
0.58
14
36
19
99
1.93
1.90
1.1
1.4
0.9
1.1
nmol/l
0.49
13
72
32
505
0.63
1.88
1.3
1.6
—
—
—
0
0
64
458
1.41
1.87
1.2
1.1
—
—
—
0
0
73
536
1.37
1.84
2.4
1.4
0.0
0.0
g/l
0.00
60
486
64
460
1.40
1.83
1.2
1.1
—
—
—
0
0
5
12
4.17
1.82
1.6
1.1
—
—
—
0
0
52
360
1.45
1.82
1.3
1.4
0.7
0.9
nmol/l
1.17
41
292
32
498
0.64
1.78
1.2
1.7
—
—
—
0
0
710
6548
1.12
1.77
4.2
4.0
11.8
8.4
mg/mmol
1.21
472
4228
94
1211
0.77
1.77
1.5
1.4
—
—
—
0
0
76
567
1.35
1.75
2.8
3.1
23.5
25.0
mmol/l
1.81
63
497
703
6485
1.12
1.74
4.6
4.0
—
—
—
0
0
16
82
1.96
1.69
1.4
1.4
—
—
—
0
0
16
82
1.96
1.69
1.4
1.4
—
—
—
0
0
80
607
1.33
1.66
2.9
1.5
33.5
47.1
mg/l
0.76
63
485
6
19
3.16
1.66
1.2
1.3
—
—
—
0
0
77
581
1.34
1.66
2.3
1.4
0.1
0.0
g/l
0.26
63
521
38
252
1.52
1.65
2.3
2.2
26.1
20.8
mg/l
0.20
11
51
80
608
1.33
1.64
2.9
1.5
53.3
49.6
mg/l
0.26
61
486
5
132
0.38
1.62
1.2
1.1
—
5.4
—
0
5
77
585
1.33
1.59
3.0
1.5
4.1
2.6
ratio
—
5
50
8
32
2.50
1.59
2.0
1.3
—
—
—
0
0
20
115
1.75
1.52
1.4
1.3
17.2
14.4
u/l
0.61
20
109
556
6047
0.89
1.52
2.1
2.2
187.1
235.7
u/l
1.17
519
5622
0
43
0.00
1.52
0.0
1.3
—
15.0
—
0
33
12
231
0.52
1.50
1.1
1.0
—
—
—
0
0
35
234
1.50
1.49
1.9
1.5
—
—
—
0
0
92
725
1.28
1.48
2.1
1.4
11.8
10.4
g/l
1.24
73
595
887
8347
1.10
1.47
4.3
3.7
0.0
0.0
estimate
0.00
197
1437
90
709
1.28
1.46
3.5
2.9
4.1
4.5
pmol/l
3.29
75
610
5
16
3.13
1.44
1.0
1.2
—
—
—
0
0
97
773
1.27
1.43
4.8
4.1
24.5
24.8
mmol/l
0.24
91
700
10
46
2.18
1.40
1.0
1.1
1373.3
1658.2
miu/ml
—
10
46
82
645
1.28
1.36
1.8
1.8
43.9
37.9
u/l
1.45
68
533
462
4226
1.12
1.32
1.9
1.8
1202.2
1167.1
nmol/l
0.32
364
3147
17
283
0.60
1.32
1.3
1.2
—
52.1
—
0
28
7
150
0.47
1.31
1.1
1.8
—
—
—
0
0
895
8468
1.09
1.29
4.3
3.7
0.0
0.0
estimate
1.08
185
1372
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
36
2.23
1.24
1.0
1.2
74.0
94.2
%
—
8
30
95
771
1.24
1.24
2.2
1.4
7.4
7.5
g/l
0.32
68
565
222
2522
0.87
1.23
15.3
7.7
—
—
—
0
0
881
8347
1.09
1.21
5.6
5.0
0.0
0.0
estimate
0.00
195
1441
5
19
2.63
1.21
1.0
1.1
—
—
—
0
0
10
188
0.53
1.20
1.2
1.4
—
—
—
0
0
76
605
1.26
1.18
1.3
1.2
—
—
—
0
0
89
723
1.24
1.16
2.3
1.4
3.1
3.1
g/l
0.05
68
558
94
769
1.23
1.15
2.2
1.4
4.0
3.9
g/l
0.55
68
548
78
625
1.26
1.15
2.3
1.4
35.3
37.3
g/l
1.93
66
514
670
6290
1.09
1.13
3.4
3.1
7.2
7.5
mmol/l
1.00
539
5222
94
771
1.23
1.13
2.2
1.4
—
—
—
0
0
7
30
2.34
1.12
1.3
1.4
43.6
76.3
u/l
—
7
24
12
66
1.82
1.09
1.2
1.1
—
—
—
0
0
80
652
1.23
1.04
2.3
1.5
0.6
0.5
g/l
0.17
66
544
10
178
0.56
1.03
1.3
1.8
—
—
—
0
0
5
23
2.18
0.98
1.4
1.8
—
—
—
0
0
9
50
1.80
0.96
1.3
1.4
16.6
9.5
ug/l
—
9
50
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
70
1.72
0.92
1.1
1.1
—
—
—
0
0
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
6
30
2.00
0.87
2.0
1.3
—
—
—
0
0
26
187
1.39
0.85
1.4
1.4
31.8
28.9
iu/l
0.13
18
158
45
569
0.79
0.85
1.3
1.4
—
—
—
0
0
456
4268
1.08
0.84
1.7
1.7
43432086.6
31440579.3
pmol/l
0.10
373
3451
15
97
1.55
0.81
2.1
1.8
15.9
17.5
nmol/l
—
10
84
14
89
1.58
0.81
1.1
1.1
—
—
—
0
0
14
89
1.58
0.81
1.1
1.1
—
—
—
0
0
19
130
1.47
0.80
1.7
1.3
0.9
1.1
promille
0.37
19
101
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
39
494
0.79
0.76
1.7
1.6
14971.4
14122.5
e6/l
0.05
25
367
17
244
0.69
0.75
1.1
1.5
47.1
64.7
%
—
10
160
180
1624
1.12
0.73
1.2
1.4
—
—
—
0
0
7
39
1.80
0.72
1.1
1.1
—
—
—
0
0
11
68
1.62
0.71
1.0
1.1
—
—
—
0
0
7
42
1.67
0.68
1.3
1.7
—
—
—
0
0
9
59
1.53
0.68
1.1
1.2
—
—
—
0
0
1235
12672
0.95
0.67
4.9
4.1
22.5
13.1
mm/h
38.23
1124
11592
19
136
1.40
0.66
1.1
1.1
—
—
—
0
0
8
128
0.62
0.64
1.0
1.1
—
—
—
0
0
325
3045
1.08
0.61
1.2
1.2
2.6
2.0
u/ml
0.27
64
781
8
50
1.60
0.61
1.3
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
55
467
1.18
0.56
2.1
2.2
119.0
132.1
g/l
2.63
42
357
5
90
0.55
0.55
2.0
2.6
—
—
—
0
0
18
239
0.75
0.54
1.5
1.3
—
—
—
0
0
12
83
1.45
0.51
1.8
1.3
—
—
—
0
0
14
101
1.39
0.49
1.0
1.1
—
—
—
0
0
14
101
1.39
0.49
1.0
1.1
—
—
—
0
0
24
189
1.27
0.49
1.4
1.2
2.1
7.3
u/ml
2.44
14
90
47
400
1.18
0.48
1.6
1.5
0.2
0.2
g/l
0.39
40
380
37
442
0.83
0.48
3.2
3.6
36.0
29.6
mg/l
0.57
28
298
7
49
1.43
0.46
1.1
1.4
—
—
—
0
0
5
83
0.60
0.45
1.0
1.1
—
—
—
0
0
5
85
0.59
0.45
1.2
1.0
—
—
—
0
0
14
103
1.36
0.45
1.0
1.1
—
—
—
0
0
14
103
1.36
0.45
1.0
1.1
—
—
—
0
0
14
103
1.36
0.45
1.0
1.1
—
—
—
0
0
39
329
1.19
0.45
1.3
1.3
—
—
—
0
0
25
201
1.25
0.45
1.4
1.2
1.5
3.1
u/ml
0.82
13
69
8
59
1.36
0.41
2.1
2.5
—
—
—
0
0
8
59
1.36
0.41
2.1
2.5
—
—
—
0
0
0
18
0.00
0.40
0.0
4.6
—
—
—
0
0
11
147
0.75
0.37
1.0
1.4
—
50.0
—
0
8
6
42
1.43
0.35
1.2
3.6
—
—
—
0
0
457
4730
0.96
0.35
1.7
1.6
18.2
19.8
nmol/l
1.97
418
3967
12
156
0.77
0.34
1.0
1.4
—
215.2
—
0
21
29
340
0.85
0.34
1.2
1.3
1.9
31.4
e6/l
1.06
18
275
68
750
0.90
0.33
1.1
1.2
193.9
126.4
iu/ml
0.31
16
281
29
339
0.85
0.33
1.3
1.3
21.3
736.5
e6/l
1.28
20
288
20
164
1.22
0.32
1.1
1.1
—
—
—
0
0
16
197
0.81
0.31
1.4
1.2
18391.3
161880.0
e6/l
1.74
11
140
39
440
0.88
0.29
1.6
1.8
57.0
43.6
nmol/l
1.88
34
416
20
167
1.20
0.28
1.0
1.1
—
—
—
0
0
36
406
0.88
0.27
1.9
1.6
—
—
—
0
0
46
510
0.90
0.26
2.8
3.2
0.8
0.8
nmol/l
0.65
35
393
46
414
1.11
0.26
1.6
1.7
—
—
—
0
0
31
273
1.14
0.25
1.4
1.2
—
—
—
0
0
12
96
1.25
0.24
1.0
1.0
—
—
—
0
0
24
208
1.16
0.24
1.3
1.3
1.3
0.7
nmol/l
0.44
24
199
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
3588.2
—
0
5
0
12
0.00
0.21
0.0
1.0
—
42.9
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
29
258
1.13
0.21
6.8
9.3
8.8
7.7
mmol/l
0.64
21
214
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
1445
14571
0.98
0.19
38.4
16.1
35.4
39.2
%
29.99
931
9064
6
51
1.18
0.19
1.3
1.2
—
—
—
0
0
42
456
0.92
0.18
1.5
1.6
2.0
7.0
iu/ml
—
10
101
5
70
0.71
0.16
1.4
2.2
10.7
127.6
ug/l
—
5
64
32
350
0.91
0.16
1.2
1.2
4.2
4.0
mmol/l
0.54
27
322
16
139
1.15
0.16
1.3
1.1
102.6
92.9
%
0.94
16
132
36
390
0.92
0.15
2.4
1.9
13.5
12.1
mg/l
0.30
30
357
27
296
0.91
0.14
1.4
1.8
2.2
4.6
iu/l
—
7
97
8
96
0.83
0.13
7.5
4.3
14.4
13.2
%
—
8
96
21
190
1.11
0.12
1.0
1.1
—
—
—
0
0
1333
13410
0.99
0.11
48.6
17.3
15.1
13.8
%
115.81
1314
13009
14
157
0.89
0.11
1.0
1.1
0.4
1.8
u/ml
—
6
65
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
19
174
1.09
0.09
1.6
2.2
2.0
1.6
u/field
—
7
66
5
62
0.81
0.08
1.2
1.0
—
—
—
0
0
7
65
1.08
0.08
1.0
1.2
—
—
—
0
0
21
195
1.08
0.08
1.1
1.4
454.1
278.7
pmol/l
0.49
16
144
6
73
0.82
0.07
1.2
1.1
—
—
—
0
0
22
207
1.06
0.06
3.7
3.8
—
—
—
0
0
394
3966
0.99
0.04
5.1
4.1
1.0
1.0
kg/l
0.02
82
608
1684
16812
1.01
0.03
39.7
14.6
36.9
26.2
mg/l
28.30
1630
13364
35
340
1.03
0.03
1.1
1.1
—
—
—
0
0
812
8133
1.00
0.01
2.1
2.1
89.4
92.5
pmol/l
1.05
427
4272
15
144
1.04
0.00
1.1
1.3
—
—
—
0
0
10
99
1.01
0.00
4.5
3.8
—
—
—
0
0
10
102
0.98
0.00
3.4
2.5
—
—
—
0
0
112
1122
1.00
0.00
2.2
2.1
11.8
14.8
nmol/l
2.73
93
955
19
187
1.02
0.00
1.1
1.1
—
13.9
—
0
6
18
180
1.00
0.00
1.3
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
67
0.90
0.00
1.2
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
0.00
1.4
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
7.9
—
0
5
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
7
71
0.99
0.00
1.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
1.5
—
0
5
6
64
0.94
0.00
13.0
12.1
1905.8
1402.1
nmol/l
—
6
64
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_BILIARY_GALLBLADDER_EXALLC – Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)
GWS hits: 2
This endpoint is excluded (different definition than used in FinnGen).